123 related articles for article (PubMed ID: 32490596)
21. Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan.
Kaur K; Kaur G
Biomed Res Int; 2013; 2013():958465. PubMed ID: 24175310
[TBL] [Abstract][Full Text] [Related]
22. Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.
Foureaux G; Nogueira JC; Nogueira BS; Fulgêncio GO; Menezes GB; Fernandes SO; Cardoso VN; Fernandes RS; Oliveira GP; Franca JR; Faraco AA; Raizada MK; Ferreira AJ
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4296-306. PubMed ID: 23702784
[TBL] [Abstract][Full Text] [Related]
23. Chitosan-based mucoadhesive microspheres of clarithromycin as a delivery system for antibiotic to stomach.
Majithiya RJ; Murthy RS
Curr Drug Deliv; 2005 Jul; 2(3):235-42. PubMed ID: 16305425
[TBL] [Abstract][Full Text] [Related]
24. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
[TBL] [Abstract][Full Text] [Related]
25. Polyvinyl Alcohol/Chitosan Single-Layered and Polyvinyl Alcohol/Chitosan/Eudragit RL100 Multi-layered Electrospun Nanofibers as an Ocular Matrix for the Controlled Release of Ofloxacin: an In Vitro and In Vivo Evaluation.
Mirzaeei S; Taghe S; Asare-Addo K; Nokhodchi A
AAPS PharmSciTech; 2021 Jun; 22(5):170. PubMed ID: 34085150
[TBL] [Abstract][Full Text] [Related]
26. Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment.
Voss K; Falke K; Bernsdorf A; Grabow N; Kastner C; Sternberg K; Minrath I; Eickner T; Wree A; Schmitz KP; Guthoff R; Witt M; Hovakimyan M
J Control Release; 2015 Sep; 214():1-11. PubMed ID: 26160303
[TBL] [Abstract][Full Text] [Related]
27. Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study.
Brandt JD; Sall K; DuBiner H; Benza R; Alster Y; Walker G; Semba CP;
Ophthalmology; 2016 Aug; 123(8):1685-1694. PubMed ID: 27157843
[TBL] [Abstract][Full Text] [Related]
28. In Vivo Evaluation of a Novel Chitosan-Polycaprolactone Based Mucoadhesive Gastro-Retentive Sustained Release Drug Delivery System for Milnacipran HCl.
Hussain T; Ijaz M; Shamim R; Hussain K; Abbas N; Hussain A; Griessinger JA; Bukhari NI
AAPS PharmSciTech; 2020 Jan; 21(2):58. PubMed ID: 31912249
[TBL] [Abstract][Full Text] [Related]
29. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
[TBL] [Abstract][Full Text] [Related]
30. Design, formulation, and evaluation of novel sustain release bioadhesive in-situ gelling ocular inserts of ketorolac tromethamine.
Jethava JK; Jethava GK
Int J Pharm Investig; 2014 Oct; 4(4):226-32. PubMed ID: 25426444
[TBL] [Abstract][Full Text] [Related]
31. [Basic and clinical studies of pressure-independent damaging factors of open angle glaucoma].
Araie M
Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):213-36; discussion 237. PubMed ID: 21476309
[TBL] [Abstract][Full Text] [Related]
32. Preparation and properties of chitosan chondroitin sulfate complex microcapsules.
Sui W; Huang L; Wang J; Bo Q
Colloids Surf B Biointerfaces; 2008 Aug; 65(1):69-73. PubMed ID: 18440788
[TBL] [Abstract][Full Text] [Related]
33. A novel nanoparticles impregnated ocular insert for enhanced bioavailability to posterior segment of eye: In vitro, in vivo and stability studies.
Rathod LV; Kapadia R; Sawant KK
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():529-540. PubMed ID: 27987741
[TBL] [Abstract][Full Text] [Related]
34. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma.
Tighsazzadeh M; Mitchell JC; Boateng JS
Int J Pharm; 2019 Jul; 566():111-125. PubMed ID: 31129346
[TBL] [Abstract][Full Text] [Related]
35. Fabrication of chondroitin sulfate-chitosan composite artificial extracellular matrix for stabilization of fibroblast growth factor.
Mi FL; Shyu SS; Peng CK; Wu YB; Sung HW; Wang PS; Huang CC
J Biomed Mater Res A; 2006 Jan; 76(1):1-15. PubMed ID: 16224775
[TBL] [Abstract][Full Text] [Related]
36. Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.
Chaiyasan W; Srinivas SP; Tiyaboonchai W
J Ocul Pharmacol Ther; 2013 Mar; 29(2):200-7. PubMed ID: 23356788
[TBL] [Abstract][Full Text] [Related]
37. pH-responsive hybrid hydrogels: Chondroitin sulfate/casein trapped silica nanospheres for controlled drug release.
Simão AR; Fragal VH; Lima AMO; Pellá MCG; Garcia FP; Nakamura CV; Tambourgi EB; Rubira AF
Int J Biol Macromol; 2020 Apr; 148():302-315. PubMed ID: 31931066
[TBL] [Abstract][Full Text] [Related]
38. Controlled-release triple anti-inflammatory therapy based on novel gastroretentive sponges: characterization and magnetic resonance imaging in healthy volunteers.
Tadros MI; Fahmy RH
Int J Pharm; 2014 Sep; 472(1-2):27-39. PubMed ID: 24928130
[TBL] [Abstract][Full Text] [Related]
39. New formulations based on salicyl-imine-chitosan hydrogels for prolonged drug release.
Iftime MM; Mititelu Tartau L; Marin L
Int J Biol Macromol; 2020 Oct; 160():398-408. PubMed ID: 32470585
[TBL] [Abstract][Full Text] [Related]
40. Efficient weapon for protracted warfare to malaria: A chondroitin sulfate derivates-containing injectable, ultra-long-lasting meshy-gel system.
Luo J; Zhang P; Liu R; Li X; Hua P; Li S; Zhang T; Zhang T; Fu Y; Song X; Gong T; Zhang Z
Carbohydr Polym; 2019 Jun; 214():131-141. PubMed ID: 30925981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
